Kukla et al. [9] and Sell et al. [18] have demonstrated higher serum chemerin concentration and Yilmaz et al. [19] have also found higher chemerin and omentin concentrations in patients with NAFLD compared to the control group. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatotic liver disease.